Skip To The Main Content
Committee & Speaker Biographies

Committee & Speaker Biographies

2021 PDA/FDA Joint Regulatory Conference

27-29 September 2021

  • James Weber

    James C. Weber

    Eli Lilly and Company
    Jim is responsible for facilitating the Digital Plant program within Eli Lilly and Company’s Manufacturing and Quality (M&Q) organization. His experience with Lilly spans 39 years in various manufacturing-related roles including operations, process automation, technical services, engineering, and various aspects of information technology. He has played lead roles in several major, global initiatives to implement new systems and business processes. Jim holds a BS in Chemical Engineering from Rose-Hulman Institute of Technology in Terre Haute, Indiana.
  • Glenn E. Wright

    Parenteral Drug Association
    GLENN E. WRIGHT is currently the VP Scientific and Regulatory Affairs, PDA. Glenn has more than 30 years of experience in the pharmaceutical industry. Previously, he served in various technical and senior leadership positions at Exelead, Eli Lilly, Amgen, and Pfizer. He has extensive technical, regulatory, and quality expertise in both small molecule and biologic drug substance manufacturing as well as sterile injectable drug product manufacturing. Glenn has served on the PDA Board of Directors, Science Advisory Board, and Program Advisory Board. In addition, he has chaired numerous PDA meetings, Task Forces, and Steering Committees. Glenn is a frequent speaker at PDA and industry events. He received his BS and MS degrees in Microbiology from Southern Illinois University.
  • Ravi Yalamanchili

    Ravi Yalamanchili, MS, MBA

    Merck & Co., Inc.

    2 years at Juno therapeutics heading Site IT and DI functions for Liso-Cel

    COO & Co-Founder of Right Mechanics Inc, Digital Health startup focused on optimizing care pathways based on patient & population health data intelligence for orthopedic patients.

    15 years at Amgen Inc leading digital transformation projects, financial results delivery projects, organizational agility and optimization initiatives.

  • Richmond Yip

    Richmond Yip

    U.S. FDA

    Richmond Yip, is a Supervisory Consumer Safety Officer with the Food and Drug Administration, ORA, Office of Pharmaceutical Quality Operations Division IV. He holds a Bachelor of Science degree in Physiological Sciences from the University of CA, Los Angeles. He currently serves as a GDUFA Supervisor within ORA overseeing a team of investigators who conduct inspections predominantly in the international pharmaceutical realm.

    Richmond began his FDA career in September 1996 as a Consumer Safety Inspector with the Los Angeles District Office. Shortly thereafter, he became an FDA Investigator assigned to conduct Pharmaceutical cGMP inspections. Richmond Yip is trained in the conduct and supervision of various pharmaceutical operations including imports, bioresearch monitoring, pre-approvals, cGMP inspections, and health fraud. While supervising his team, he also serves as a liaison between CDER, Industry, State, other federal officials and FDA field staff in the conduct of drug inspections. Certified Green Belt in Six Sigma, he also serves as a Program advisor on the management and execution of field operations.